Tag: Coronary
Coronary stents market in APAC to see sustained growth through 2034:...
The market is poised to grow at a compound annual growth rate (CAGR) of 3.2% in APAC between 2024 and 2034, outpacing the global CAGR of 1.2% over the same period
SS Innovations makes history with first robotic cardiac surgery in Indonesia
Dr Sudhir Srivastava, Founder, Chairman, and CEO of SS Innovations, made history in Indonesia by successfully performing the first Beating Heart Totally Endoscopic Coronary Artery Bypass
India coronary stent market set for 4% CAGR growth during 2024-2033,...
India’s coronary drug eluting stent market accounts for around 32% of the Asia-Pacific market in 2024
66% of Indians tested have elevated levels of homocysteine in blood:...
High homocysteine level is a risk factor for atherosclerosis and coronary artery disease
Less than one in four Indians aware brain stroke symptoms: Survey
Only 41% of respondents consider brain stroke a cause of concern. Just 23% of respondents were aware about risk factors of brain stroke
New drug for coronary diseases could be in offing
An agreement between CSIR-CDRI and Marc Laboratories could pave the way for developing a synthetic compound S-007-867 as modulator of blood coagulation cascade, in particular as inhibitor of collagen-induced platelet aggregation....................
Innovative imaging technology promises improved cardiac care
iOPTICO is based on Optical Coherence Tomography (OCT), the latest imaging technology in the field of coronary intervention.................
Fixing medicine prices saved ₹11,462 crore for patients: Govt
As per the union minister, Mr Mansukh L. Mandaviya, the ceiling prices of 856 medicines fixed by the National Pharmaceutical Pricing Authority (NPPA), resulted in a saving of Rs 11,462 crore for patients. He ruled out any shortage of coronary stents due to price fixation...…………...
Govt says it fixed ceiling prices of 849 medicines, including 2...
While 59 of the formulations witnessed maximum 40 percent reduction, the minimum 5 percent was the reduction rate in case of 233 formulations...........
MedTech industry needs consensus, not confrontation!
The union government has gone tough on medical technology accessibility and affordability. While the stent prices have been capped, the responsibility to keep them available lies with companies....Read Editor's Take.....